![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, September 06, 2018 6:45:01 PM
As such, Derbyshire NHS decided not to accept the Actipatch for the same reason the NHS accepted the Actipatch. It is like go figure.
At any rate, BIEL is appealing the decision on that front. But Derbyshire NHS may to tell them go F themselves. They will tell them your own country does not even allow you to sell back pain Actipatch and now you are asking us to do it. Get your own country approval first.
ActiPatch
BNFStatusBlackDecision Date August 2018
Comments
Wearable medical device
Black Drug Classifications
4: Have a lack of data on cost-effectiveness compared with standard therapy
5: Less cost-effective than current standard therapy
< search again
http://www.derbyshiremedicinesmanagement.nhs.uk/home/full_traffic_light_classification/show_drug/actipatch/
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM